Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis

Background: In recent years, biologics targeting key cytokines and Janus kinase (JAK) inhibitors have demonstrated favorable efficacy and safety outcomes for atopic dermatitis (AD) therapy. To evaluate the short-term efficacy and safety of AD therapy involving biologics, JAK inhibitors, and their co...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Qianyu Chen, Lian Cui, Yifan Hu, Zeyu Chen, Yunlu Gao, Yuling Shi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-11-01
Edice:	Heliyon
Témata:	Atopic dermatitis Biologics Janus kinase inhibitors
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2405844023092228
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!